Deborah Brown shares key findings from the recently released seventh annual "State of Lung Cancer" report. The campaign kicked off on November 1 to coincide with Lung Cancer Awareness Month. Deborah Brown shares how the American Lung Association and its LUNG FORCE initiative are raising awareness this month. Dr. MarkAlain Déry opines on micro and macro level systemic changes that are needed to improve health care amid hurricanes. Hurricanes Helene and Milton had a deleterious impact on medical dispensing. Dr. Dery details the impact of these shortages. Dr. Déry talks about how health disparities are amplified during hurricanes, and which communities are most impacted. Dr. Déry details, with the use of specific examples, how hurricanes negatively impact the mental health of HCPs. Dr. Déry provides a comprehensive overview of mass casualty protocols and how they are implemented during hurricanes. Dr. MarkAlain Déry details the dangers associated with power failures at health care facilities, and how they are managed. In the 20 years post-Hurricane Katrina, many natural disaster protocols have changed in an effort to improve preparedness. There are a plethora of obstacles, especially regarding infrastructure, that health care facilities face during hurricanes. Dr. Studts discusses why Lung Cancer Awareness Month is a critical time to inspire action, engagement, and hope. Dr. John Fruehauf, Evolent, talks about a new standard of care in the treatment of stage III melanoma. Researchers conducted an extensive analysis of PM2.5 exposure based on residential history, satellite data, and more. Jonathan Barratt discussed his research on the anti-APRIL antibody sibeprenlimab in the treatment of IgA nephropathy. Abdul Abdellatif discussed findings from the PROTECT study examining pegloticase for kidney transplant patients with gout. Mia Grisco, a young person living with narcolepsy, shared her perspective on the FDA's recent approval of Avadel's LUMRYZ. Dr. Anne Marie Morse breaks down the connection between diet and sleep quality. Lung Cancer Awareness Month is observed every November and represents a key time to take action and raise awareness. Arthi Sridhar, MD, discusses the real-world study, which was presented at the IASLC 2024 World Conference on Lung Cancer. Learn what the global survey showed about the rates of biomarker testing and the remaining barriers to implementation.